This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Rey, C.
Right arrow Articles by Dal-Ré, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Rey, C.
Right arrow Articles by Dal-Ré, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2002, p. 159-164, Vol. 40, No. 1
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.1.159-164.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae

César García-Rey,1* Lorenzo Aguilar,1 Fernando Baquero,2 Julio Casal,3 and Rafael Dal-Ré1

Medical Department, GlaxoSmithKline,1 Clinical Microbiology Department, Hospital Ramón y Cajal,2 Microbiology Department, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain3

Received 30 July 2001/ Returned for modification 17 September 2001/ Accepted 22 October 2001

A geographical analysis of how commonly prescribed oral antibiotics are quantitatively and qualitatively responsible for the different local rates of erythromycin and penicillin resistance in Streptococcus pneumoniae in Spain is presented. From 1998 to 1999 a multicenter surveillance study yielded 1,684 consecutive S. pneumoniae isolates from community-acquired respiratory infections. Data on antibiotic sales in the retail market for the same period were gathered, and the corresponding defined doses per 1,000 inhabitants per day were calculated. Macrolides and ß-lactams were considered separately. Macrolides were subdivided into thrice-, twice-, and once-a-day macrolides, and ß-lactams were split into aminopenicillins and cephalosporins. Univariate Spearman nonparametric coefficients (R) were calculated, and variables proving to be significantly associated (P < 0.1) were entered into several multiple lineal regression models. Ample variation in both resistance rates and antibiotic consumption was seen. Multivariate analyses showed that integrated consumption of both macrolides and ß-lactams accounted well for erythromycin (R2 = 0.722; P = 0.002) and penicillin (R2 = 0.706; P = 0.002) resistance. Macrolides were more important drivers for local differences in both erythromycin and penicillin resistance than ß-lactams were. Consumption of once-a-day macrolides was key for local erythromycin resistance variations. Cephalosporins were slightly more important penicillin resistance drivers than aminopenicillins were.

* Corresponding author. Mailing address: GlaxoSmithKline Medical Department, c/ Severo Ochoa, 2, P. T. M. Tres Cantos, 28760-Madrid, Spain. Phone: 34 91 807 5738. Fax: 34 91 807 0596. E-mail: cesar.garcia-rey{at}gsk.com.

Journal of Clinical Microbiology, January 2002, p. 159-164, Vol. 40, No. 1
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.1.159-164.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Glass, S. K., Pearl, D. L., McEwen, S. A., Finley, R. (2009). Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006). J Antimicrob Chemother 0: dkp391v1-dkp391 [Abstract] [Full Text]  
  • Fenoll, A., Granizo, J. J., Aguilar, L., Gimenez, M. J., Aragoneses-Fenoll, L., Hanquet, G., Casal, J., Tarrago, D. (2009). Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007. J. Clin. Microbiol. 47: 1012-1020 [Abstract] [Full Text]  
  • Meropol, S. B. (2008). Valuing Reduced Antibiotic Use for Pediatric Acute Otitis Media. Pediatrics 121: 669-673 [Abstract] [Full Text]  
  • Cadieux, G. MSc, Tamblyn, R. PhD, Dauphinee, D. MD, Libman, M. MD (2007). Predictors of inappropriate antibiotic prescribing among primary care physicians. CMAJ 177: 877-883 [Abstract] [Full Text]  
  • Van Eldere, J., Mera, R. M., Miller, L. A., Poupard, J. A., Amrine-Madsen, H. (2007). Risk Factors for Development of Multiple-Class Resistance to Streptococcus pneumoniae Strains in Belgium over a 10-Year Period: Antimicrobial Consumption, Population Density, and Geographic Location. Antimicrob. Agents Chemother. 51: 3491-3497 [Abstract] [Full Text]  
  • Hawkyard, C. V., Koerner, R. J. (2007). The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother 59: 347-358 [Abstract] [Full Text]  
  • Al Khaja, K. A. J., Al-Ansari, T. M., Damanhori, A. H. H., Sequeira, R. P. (2006). Rational Use of Antimicrobials in Infants in Primary Care of Bahrain. J Trop Pediatr 52: 390-393 [Abstract] [Full Text]  
  • Bergman, M., Huikko, S., Huovinen, P., Paakkari, P., Seppala, H., Finnish Study Group for Antimicrobial Resistance (, (2006). Macrolide and Azithromycin Use Are Linked to Increased Macrolide Resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 50: 3646-3650 [Abstract] [Full Text]  
  • Coenen, S., Ferech, M., Malhotra-Kumar, S., Hendrickx, E., Suetens, C., Goossens, H., on behalf of the ESAC Project Group, (2006). European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe. J Antimicrob Chemother 58: 418-422 [Abstract] [Full Text]  
  • Alvarez-Sala, J.-L., Kardos, P., Martinez-Beltran, J., Coronel, P., Aguilar, L., the Cefditoren AECB Working Group, (2006). Clinical and Bacteriological Efficacy in Treatment of Acute Exacerbations of Chronic Bronchitis with Cefditoren-Pivoxil versus Cefuroxime-Axetil.. Antimicrob. Agents Chemother. 50: 1762-1767 [Abstract] [Full Text]  
  • Jumbe, N. L., Louie, A., Miller, M. H., Liu, W., Deziel, M. R., Tam, V. H., Bachhawat, R., Drusano, G. L. (2006). Quinolone Efflux Pumps Play a Central Role in Emergence of Fluoroquinolone Resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 50: 310-317 [Abstract] [Full Text]  
  • Voils, S. A, Evans, M. E, Lane, M. T, Schosser, R. H, Rapp, R. P (2005). Use of Macrolides and Tetracyclines for Chronic Inflammatory Diseases. The Annals of Pharmacotherapy 39: 86-94 [Abstract] [Full Text]  
  • Bruinsma, N., Kristinsson, K. G., Bronzwaer, S., Schrijnemakers, P., Degener, J., Tiemersma, E., Hryniewicz, W., Monen, J., Grundmann, H., on behalf of EARSS participants, (2004). Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother 54: 1045-1050 [Abstract] [Full Text]  
  • Garcia-Rey, C., Fenoll, A., Aguilar, L., Casal, J. (2004). Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain. J Antimicrob Chemother 54: 465-471 [Abstract] [Full Text]  
  • Low, D. E., Pichichero, M. E., Schaad, U. B. (2004). Optimizing Antibacterial Therapy for Community-Acquired Respiratory Tract Infections in Children in an Era of Bacterial Resistance. CLIN PEDIATR 43: 135-151 [Abstract]  
  • Dean, N. C. (2003). Encouraging News From the Antibiotic Resistance Front. Chest 124: 423-424 [Full Text]  
  • Waterer, G. W., Buckingham, S. C., Kessler, L. A., Quasney, M. W., Wunderink, R. G. (2003). Decreasing {beta}-Lactam Resistance in Pneumococci From the Memphis Region: Analysis of 2,152 Isolates From 1996 to 2001. Chest 124: 519-525 [Abstract] [Full Text]  
  • Van Kerkhoven, D., Peetermans, W. E., Verbist, L., Verhaegen, J. (2003). Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral {beta}-lactams. J Antimicrob Chemother 51: 691-696 [Abstract] [Full Text]  
  • Garcia-Rey, C., Aguilar, L., Baquero, F., Casal, J., Martin, J. E. (2002). Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain. J. Clin. Microbiol. 40: 2959-2963 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»